Across TCGA patient cohorts, RNU6-282P RNA expression is significantly associated with the go_rna of many other GO terms, with 7,122 significant associations in total. KIRC shows the largest number of these associations.

The most reproducible RNU6-282P-associated GO terms across cancer lineages are Nuclear-transcribed mRNA poly(A) tail shortening, Vesicle targeting, and RISC complex assembly. Each is linked with RNU6-282P in more than 31 cancer types. Because this analysis shows association rather than direction, both RNU6-282P-to-partner and partner-to-RNU6-282P results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RNU6-282P→partner) and Y-score (partner→RNU6-282P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
DLBC	Nuclear-transcribed mRNA poly(A) tail shortening →	+0.075	+1.070	<.001	<.001	3	32
STAD	Vesicle targeting →	+0.058	+0.659	<.001	<.001	3	31
DLBC	RISC complex assembly →	+0.062	+0.914	<.001	<.001	3	31
STAD	Maintenance of cell number →	+0.053	+0.679	<.001	<.001	3	31
STAD	RNA secondary structure unwinding →	+0.072	+0.818	<.001	<.001	3	31
DLBC	Obsolete histone methylation →	+0.070	+0.797	<.001	<.001	3	31

Each partner links to its Q-omics profile. Showing the 6 strongest of 7,122 associations by consensus.

Exploration

RNU6-282P survival (RNA) · tumor vs normal (RNA) · all RNU6-282P data types